EUVIMEDEUVIMED entdecken
Crossref

CD44 and CD133 Expressions in Primary Tumor Cells Correlate to Survival of Pancreatic Cancer Patients

Shinichi Maeda, Ding Qiang, Hiroyuki Shinchi, Hiroshi Kurahara, Yuko Mataki, Kousei Maemura, Shoji Natsugoe, Sonshin Takao

The Open Surgical Oncology Journal · 2009

DOI: 10.2174/1876504100901010001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Open Surgical Oncology Journal, 2009. Verfasst von Shinichi Maeda und 7 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Recent studies have suggested that CD44 and/or CD133 expressing pancreatic cancer cells have potential abilities of self-renewal, tumorigenesis and tumor metastasis.The aim of this study was to investigate whether CD44 and CD133 expressions in primary tumor cells correlate to the survival and clinicopathological findings of pancreatic cancer patients.

Methods

Pancreatic head carcinoma specimens from 80 patients who underwent surgical resection were immunohistochemically assessed for CD44 and CD133 expressions.

Results

Of the 80 specimens, 34 (42.5 %) and 48 (60%) specimens were immunohistochemically positive for CD44 and CD133 expression, respectively.CD44 was expressed on the cell surface and CD133 expression was observed in the cytoplasm of the positive cells, which were located at the peripheral adenocarcinoma glandular structures.There was no significant difference in the 5-year survival rate of patients based on CD44 expression, but the 5-year survival rate of CD133-positive patients was significantly lower than that of CD133-negative patients (P = 0.0002).Multivariate analysis revealed that CD44-positive and CD133-negative expression was a favorable prognostic indicator (P = 0.0424).

Conclusions

CD44 and CD133 expressions are association with survival and malignant behavior in pancreatic cancer patients.

Zitieren

APA

Maeda, S., Qiang, D., Shinchi, H., Kurahara, H., Mataki, Y., Maemura, K., Natsugoe, S., & Takao, S. (2009). CD44 and CD133 Expressions in Primary Tumor Cells Correlate to Survival of Pancreatic Cancer Patients. The Open Surgical Oncology Journal. https://doi.org/10.2174/1876504100901010001

Vancouver

Maeda S, Qiang D, Shinchi H, Kurahara H, Mataki Y, Maemura K, et al. CD44 and CD133 Expressions in Primary Tumor Cells Correlate to Survival of Pancreatic Cancer Patients. The Open Surgical Oncology Journal. 2009. doi:10.2174/1876504100901010001

BibTeX
@article{Maeda2009,
  author = {Maeda, Shinichi and Qiang, Ding and Shinchi, Hiroyuki and Kurahara, Hiroshi and Mataki, Yuko and Maemura, Kousei and Natsugoe, Shoji and Takao, Sonshin},
  title = {CD44 and CD133 Expressions in Primary Tumor Cells Correlate to Survival of Pancreatic Cancer Patients},
  journal = {The Open Surgical Oncology Journal},
  year = {2009},
  doi = {10.2174/1876504100901010001}
}
Kostenlos starten →